Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001193125-26-104111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-10 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +136.6K | 658.0K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-03-10 | A | A | 136,612 | $0.00 | 658,037 | D | — | — |